Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Inovio Pharmaceuticals Inc. (INO)

3.745   0.105 (2.88%) 02-21 16:00
Open: 3.73 Pre. Close: 3.64
High: 3.88 Low: 3.57
Volume: 7,521,551 Market Cap: 386M
Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.794 - 3.815 3.815 - 3.832
Low: 3.521 - 3.546 3.546 - 3.567
Close: 3.602 - 3.64 3.64 - 3.673

Technical analysis

as of: 2020-02-21 3:56:12 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 5.70     One year: 6.95
Support: Support1: 3.14    Support2: 2.61
Resistance: Resistance1: 4.88    Resistance2: 5.95
Pivot: 3.72
Moving Average: MA(5): 3.90     MA(20): 3.93
MA(100): 2.90     MA(250): 2.98
MACD: MACD(12,26): 0.07     Signal(9): 0.10
Stochastic oscillator: %K(14,3): 33.49     %D(3): 36.36
RSI: RSI(14): 50.05
52-week: High: 5.95  Low: 1.92  Change(%): -2.2
Average Vol(K): 3-Month: 612924  10-Days: 1375766

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
INO has closed above bottom band by 48.0%. Bollinger Bands are 44.2% wider than normal. The large width of the bands suggest high volatility as compared to INO's normal range. The bands have been in this wide range for 19 bars. This is a sign that the current trend might continue.

Headline News

Tue, 18 Feb 2020 14:16:49 +0000
Moderna Will Rebound, But Wait for a Dip Lower to Buy Shares

Tue, 18 Feb 2020 18:14:00 +0000
Sanofi Gets Backing From U.S. Government to Develop a COVID-19 Vaccine

Mon, 17 Feb 2020 15:57:00 +0000
The FDA Has a Plan to Deal With the Coronavirus

Thu, 13 Feb 2020 17:25:45 +0000
Inovio’s Surge on a Coronavirus Vaccine Was Just Speculation

Wed, 12 Feb 2020 13:11:53 +0000
Pandemic Fears Not Enough to Buy Inovio Stock

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 101.36
Shares Float (M) 96.32
% Held by Insiders 4.75
% Held by Institutions 40.95
Shares Short (K) 10420
Shares Short P. Month (K)

Stock Financials

EPS -1.175
Book Value (p.s.) 0.340
PEG Ratio
Profit Margin
Operating Margin -1704.95
Return on Assets (ttm) -46.2
Return on Equity (ttm) -165.0
Qtrly Rev. Growth -56.7
Gross Profit (p.s.) -0.639
Sales Per Share
EBITDA (p.s.) -1.018
Qtrly Earnings Growth
Operating Cash Flow (M) -101.39
Levered Free Cash Flow (M) -63.59

Stock Valuations

P/E -3.14
P/E Growth Ratio 0.02
P/BV 10.87
P/S 61.58
P/CF -3.69

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2014-06-05
Last Split Ratio 0.25
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.